Accurate identification of products and medical devices helps to improve traceability through the supply chain and patient pathway.
GTIN adoption for UDI
Unique identification is particularly important for medical device traceability and patient safety. Many medical devices now use GS1 GTINs as the primary unique device identifier (UDI).
In a survey conducted with Portsmouth Hospitals University NHS Trust and GS1 Healthcare, we tested more than 2400 medical devices to gauge adoption.
More than 95% of the 2433 medical devices assessed use a GS1 GTIN for UDI.
More suppliers using GS1 GTINs as the primary unique device identifier than in 2018.
Use of the GS1 2D DataMatrix on product packaging has nearly doubled since 2018.
To help make sure your barcodes are right first time, we have developed a series of short webinars to take you through what you need to know. Find out more in the barcoding success bitesize series by following the link below.
Barcode scanning in hospitals
To support medical device traceability, the UK government issued a mandate to NHS England to promote the adoption of barcode scanning for high-risk medical devices.
By March 2024, NHS trusts in England will be required to implement scanning to capture accurate device information in support of the Medical Device Outcomes Registry (MDOR).
GS1 is an authorised issuing entity for UDI for many global medical device regulations. GS1 members can use GS1 GTINs to comply with necessary UDI requirements. Many medical devices now use GS1 GTINs as the primary unique device identifier.
To help improve traceability and patient safety, the EU and the US have both published UDI regulations for medical devices. These regulations join a globally harmonised framework for identification of medical devices – enhancing quality of care, patient safety and business processes. Each regulation has similar requirements that differ in places, have different timescales and use different databases for manufacturers to update.
The UK Medicines and Healthcare products Regulatory Agency (MHRA) are reviewing the UDI requirements for legislation in Great Britain.
Following the UK departure from Europe, the European Medical Device Regulation (EU MDR) and In-vitro Diagnostic Medical Device Regulations (IVDR) will not apply in Great Britain (GB). Legislation that will apply in GB will be the Medical Device Regulations 2002.
The MHRA will be using the Medicines and Medical Devices Act to improve the traceability of medicines and medical devices. By standardising the way devices are identified (using unique device identification – UDI), this will enable devices to be tracked and traced once on the market.
Device reference data will then be captured and held in a national medical device register to improve post-market surveillance. This includes: proactively monitoring device performance for re-certification, annual safety updates for higher-risk class devices, rapid reporting of safety incidents, and facilitation of efficient product recalls.
The register is intended to hold details of manufacturers and all relevant production information of devices placed on the GB market.
Registration of devices in GB are to be no later than 1 May 2021, 1 September 2021, and 1 January 2022 for relevant device classes.
The European Union published the regulations on medical devices and in-vitro diagnostics in April 2017. Original dates listed have since been updated to the timelines outlined below as highlighted in the European Commission's Unique Device Identification (UDI) System – FAQs document.
Compliance timelines in the EU
|Class of device||UDI assignment||Submission of UDI core data elements to the database||Placement of the UDI carrier e.g. barcodes on products|
|Implantable devices and Class III devices||26 May 2021||26 Nov 2022||26 May 2021|
|Class Ila and Class llb devices||26 May 2021||26 Nov 2022||26 May 2023|
|Class I devices||26 May 2021||26 Nov 2022||26 May 2025|
|Reusable devices that shall bear the UDI Carrier on the device itself||26 May 2021||26 Nov 2022||2 years after the date applicable for its respective class of devices|
|Class D IVDs||26 May 2022||26 Nov 2023||26 May 2023|
|Class C and B IVDs||26 May 2022||26 Nov 2023||26 May 2025|
|Class A IVDs||26 May 2022||26 Nov 2023||26 May 2027|
The release of EUDAMED modules
The European Commission (EC) has officially confirmed that the EUDAMED UDI/Devices registration, and Notified Bodies and Certificates modules have been successfully deployed in the Production environment and are now available for use. The remaining modules will be displayed as soon as they are functional.
New EUDAMED release dates (updated as of October 2023)
- The new target date for EUDAMED full functionality is Q2 2027.
- The new target date for mandatory use of Actor module, Market Surveillance module, Vigilance module and CIPS module is Q4 2027.
- The new target date for mandatory use of Devices module (incl. UDI) and Certificates modules is Q4 2029.
You can find further information on the full EUDAMED implementation roadmap.
European Commission's UDI Helpdesk
The European Commission has launched a dedicated UDI helpdesk to support organisations with implementing the obligations and requirements of the new UDI system under regulations (EU) 2017/745 on medical devices (MDR) and (EU) 2017/746 on in vitro diagnostic medical devices (IVDR).
It has been developed to provide additional support with regards to UDI assignment, labelling and registration of devices, as well as guidance on the use of the European Medical Devices Nomenclature (EMDN).
The US Food and Drug Administration (FDA) has had a Unique Device Identification (UDI) system for medical devices sold into the US since 2013.
Compliance timelines in the US
|24 September 2014||Class III; Labels and packages of all Class III medical devices and devices listed under the Public Health Service Act must have a UDI. Data for these devices must be submitted to the Global UDI Database (GUDID).|
|25 September 2015||Labels and packages of implantable, life-supporting and life-sustaining devices must have a UDI. Data for these devices must be submitted to the GUDID.|
|24 September 2016||Class II; Labels and packages of Class II medical devices must have a UDI. Data for these devices must be submitted to the GUDID.|
|24 September 2018||Class I; Labels and packages of Class I medical devices that have not been classified as Class I, II or III must have a UDI. Data for these devices must be submitted to the GUDID.|
FDA Extends Alternatives UDI-A160001 and UDI-A160002
The U.S. Food and Drug Administration (FDA) has extended the following unique device identifier (UDI) alternatives UDI-A160001 and UDI-A160002.
This extension means certain non-prescription, over-the-counter devices intended to be sold exclusively through retail establishments may continue to bear a Universal Product Code (UPC) as their device identifier.
These two alternatives expire on 24 September 2023.
For more information on the alternatives and a list of the FDA product codes to which the alternatives apply, click "learn more" below, to go to the FDA Decisions section of the UDI Exceptions, Alternatives, and Time Extensions page on FDA.gov.
If you have any further questions, contact the FDA UDI Help Desk via the link below.